NCT02605083 2020-11-02A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid TumorsEffector TherapeuticsPhase 1/2 Terminated66 enrolled
NCT02937675 2020-11-02A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological MalignanciesEffector TherapeuticsPhase 1/2 Terminated28 enrolled